Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression

Psychiatry and Clinical Neurosciences

Volumn 62, Issue 1, 2008, Pages 75-83

  Kim, Sung Wan ^a,b   Shin, Il Seon ^a,b   Kim, Jae Min ^a,b   Kim, Young Chul ^a   Kim, Kyu Sik ^a   Kim, Ki Min ^a   Yang, Su Jin ^a,b   Yoon, Jin Sang ^a,b  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

Cancer; Depression; Insomnia; Mirtazapine; Nausea

Indexed keywords

MIRTAZAPINE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONSTIPATION; DEPRESSION; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HEALTH SURVEY; HUMAN; INSOMNIA; LUNG CANCER; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MUSCLE WEAKNESS; NAUSEA; NIGHT SLEEP; PAIN ASSESSMENT; PROSPECTIVE STUDY; SEDATION; SIDE EFFECT; SLEEP DISORDER; VISUAL ANALOG SCALE;

ADJUSTMENT DISORDERS; ADMINISTRATION, ORAL; ADULT; AGED; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIANSERIN; MIDDLE AGED; NAUSEA; NEOPLASMS; PROSPECTIVE STUDIES; SICK ROLE; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME;

EID: 39149118868     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2007.01778.x     Document Type: Article

References (34)

1. Grond S, Zech D, Diefenbach C, Bischoff A. Prevalence and pattern of symptoms in patients with cancer pain: A prospective evaluation of 1635 cancer patients referred to a pain clinic. J. Pain Symptom Manage. 1994 9 : 372 382.
2. Massie MJ. Prevalence of depression in patients with cancer. J. Natl Cancer Inst. Monogr. 2004 32 : 57 71.
3. Theobald DE. Cancer pain, fatigue, distress, and insomnia in cancer patients. Clin. Cornerstone 2004 6 (Suppl. 15 21.
4. Lee K, Cho M, Miaskowski C, Dodd M. Impaired sleep and rhythms in persons with cancer. Sleep Med. Rev. 2004 8 : 199 212.
5. Andrews JM, Nemeroff CB. Contemporary management of depression. Am. J. Med. 1994 97 (Suppl. 24 32.
6. Pinder RM. The pharmacology of mirtazapine. J. Clin. Psychiatry 1997 58 : 501 502.
7. Guclu S, Gol M, Dogan E, Saygili U. Mirtazapine use in resistant hyperemesis gravidarum: Report of three cases and review of the literature. Arch. Gynecol. Obstet. 2005 272 : 298 300.
8. Teixeira FV, Novaretti TM, Pilon B, Pereira PG, Breda MF. Mirtazapine (Remeron) as treatment for non-mechanical vomiting after gastric bypass. Obes. Surg. 2005 15 : 707 709.
9. Kim SW, Shin IS, Kim JM et al. Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment. Psychosomatics 2006 47 : 440 442.
10. Pae CU. Low-dose mirtazapine may be successful treatment option for severe nausea and vomiting. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006 30 : 1143 1145.
11. Winokur A, Sateia MJ, Hayes JB, Bayles-Dazet W, MacDonald MM, Gary KA. Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: A pilot study. Biol. Psychiatry 2000 48 : 75 78.
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV). American Psychiatric Press, Washington, DC, 1994.
13. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 1979 134 : 382 389.
14. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med. Care 1992 30 : 473 483.
15. Kind P. The EuroQoL Instrument: An index of HRQOL. In : Spilker B (ed.). Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd edn. Lippincott-Raven, Philadelphia, 1996 191 201.
16. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta. Psychiatr. Scand. Suppl. 1987 334 : 1 100.
17. Trovato JA, Stull DM, Finley RS. Outcomes of antiemetic therapy after the administration of high-dose antineoplastic agents. Am. J. Health Syst. Pharm. 1998 55 : 1269 1274.
18. Parrot AC, Hindmarch I. The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigation: A review. Psychopharmacology 1980 71 : 173 179.
19. Davis MP, Khawam E, Pozuelo L, Lagman R. Management of symptoms associated with advanced cancer: Olanzapine and mirtazapine. A World Health Organization project. Expert Rev. Anticancer. Ther. 2002 2 : 365 376.
20. Thompson DS. Mirtazapine for the treatment of depression and nausea in breast and gynecological oncology. Psychosomatics 2000 41 : 356 359.
21. Theobald DE, Kirsh KL, Holtsclaw E, Donaghy K, Passik SD. An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms. J. Pain Symptom Manage. 2002 23 : 442 447.
22. Kast RE. Mirtazapine may be useful in treating nausea and insomnia of cancer chemotherapy. Support. Care Cancer 2001 9 : 469 470.
23. Davidson JR, MacLean AW, Brundage MD, Schulze K. Sleep disturbance in cancer patients. Soc. Sci. Med. 2002 54 : 1309 1321.
24. Radhakishun FS, van den Bos J, van der Heijden BC, Roes KC, O'Hanlon JF. Mirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimens. J. Clin. Psychopharmacol. 2000 20 : 531 537.
25. Van Gool AR, Bannink M, Stronks DL, Vos MS. Re: Mirtazapine in cancer patients. J. Pain Symptom Manage. 2003 25 : 7 8.
26. Onghena P, Van Houdenhove B. Antidepressant-induced analgesia in chronic non-malignant pain: A meta-analysis of 39 placebo-controlled studies. Pain 1992 49 : 205 219.
27. Bendtsen L, Jensen R. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 2004 62 : 1706 1711.
28. Samborski W, Lezanska-Szpera M, Rybakowski JK. Open trial of mirtazapine in patients with fibromyalgia. Pharmacopsychiatry 2004 37 : 168 170.
29. Freynhagen R, Muth-Selbach U, Lipfert P et al. The effect of mirtazapine in patients with chronic pain and concomitant depression. Curr. Med. Res. Opin. 2006 22 : 257 264.
30. Wilson KG, Eriksson MY, D'Eon JL, Mikail SF, Emery PC. Major depression and insomnia in chronic pain. Clin. J. Pain 2002 18 : 77 83.
31. Aukst-Margetic B, Jakovljevic M, Margetic B, Biscan M, Samija M. Religiosity, depression and pain in patients with breast cancer. Gen. Hosp. Psychiatry 2005 27 : 250 255.
32. Massie MJ, Holland JC. The cancer patient with pain: Psychiatric complications and their management. J. Pain Symptom Manage. 1992 7 : 99 109.
33. Kim K, Johnson JA, Derendorf H. Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms. J. Clin. Pharmacol. 2004 44 : 1083 1105.
34. Yoon SJ, Pae CU, Kim DJ et al. Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: A multicentre, open label study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006 30 : 1196 1201.